Compare PLRX & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | VREX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 783.5M |
| IPO Year | 2020 | 2016 |
| Metric | PLRX | VREX |
|---|---|---|
| Price | $1.06 | $18.47 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $2.67 | ★ $18.90 |
| AVG Volume (30 Days) | 360.8K | ★ 555.5K |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $811,000,000.00 |
| Revenue This Year | N/A | $2.52 |
| Revenue Next Year | N/A | $3.97 |
| P/E Ratio | ★ N/A | $80.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $9.09 |
| 52 Week High | $1.95 | $18.63 |
| Indicator | PLRX | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 77.26 |
| Support Level | $1.02 | $12.00 |
| Resistance Level | $1.37 | $18.63 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 18.18 | 20.83 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.